COHR

Coherent, Inc.

70
Fundamentals72/ 100
Valuation44/ 100
Upside potential88/ 100
Risk potential19/ 100

COHR's fundamentals are strong: revenue grew 31% and its operating margin rose 8 points to 13%, though free cash flow turned negative. At 48x earnings, it's trading above its usual 34x. Analysts expect that strong growth to continue.

QBTS

D-Wave Quantum Inc.

There isn't enough reported data to score QBTS yet.

COHR Fundamentals

MetricStatus
Strong
Strong
Weak
Healthy

COHR's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

QBTS Fundamentals

MetricStatus
Under pressure
Weak
Weak
Unavailable

QBTS's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.

COHR PE Valuation

CHEAPFAIREXPENSIVE87x174x261x348x
CHEAPFAIREXPENSIVE87x174x261x348x
LevelPEPriceVs current
Forward20x$232โ€”
Cheap27x$130-44%
Fair34x$165-29%
Current48x$232โ€”
Expensive184x$886+282%

Historical ranges are pointers, not guarantees.

COHR's PE is in its fair range at 48x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its cheap range.

QBTS PE Valuation

QBTS has no meaningful PE right now: it lost money over the past year.

COHR Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for COHR, with profitability improving.

QBTS Forward outlook

MetricOutlook
--
Losses steady
Strong growth
--
Limited
Low

Analysts expect QBTS's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.

COHR Risk to reward

ScenarioChangePrice
Upside+138%$551.66
Downside-19%$187.45

Calculated from the latest close: $232.08 on Nov 12.

There is not enough scenario data to compare COHR and QBTS's risk to reward.

QBTS Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $9.84 on Nov 12.

There is not enough scenario data to compare COHR and QBTS's risk to reward.

COHR Earnings Per Share

Q4 2023: $-2.82Q1 2024: $-2.87Q2 2024: $-1.84Q3 2024: $-1.23Q4 2024: $-0.41Q1 2025: $-0.23Q2 2025: $-0.52Q3 2025: $0.71Q4 2025: $1.03Q1 2026: $2.11Q2 2026: $4.12Q3 2026: $4.83Forward: $11.69
Q4 2023: $-2.82Q1 2024: $-2.87Q2 2024: $-1.84Q3 2024: $-1.23Q4 2024: $-0.41Q1 2025: $-0.23Q2 2025: $-0.52Q3 2025: $0.71Q4 2025: $1.03Q1 2026: $2.11Q2 2026: $4.12Q3 2026: $4.83Forward: $11.69
QuarterTTM EPSYoY
Forward$11.69+142%
Q3 2026$4.83+580%
Q2 2026$4.12+$4.64
Q1 2026$2.11+$2.34
Q4 2025$1.03+$1.44
Q3 2025$0.71+$1.94
Q2 2025-$0.52+$1.32
Q1 2025-$0.23+$2.64
Q4 2024-$0.41+$2.41

COHR has the edge over QBTS in the latest year-over-year earnings comparison.

QBTS Earnings Per Share

Q3 2025: $-1.41Q4 2025: $-1.11Q1 2026: $-1.14Q2 2026: $-0.72Q3 2026: $-0.44
Q3 2025: $-1.41Q4 2025: $-1.11Q1 2026: $-1.14Q2 2026: $-0.72Q3 2026: $-0.44
QuarterTTM EPSYoY
Q3 2026-$0.44+$0.97

QBTS is still losing money, but far less than before: $0.44 per share over the past year, against $1.41 at its worst in late 2025.

COHR Quarterly Revenue

Q4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.5BQ2 2025: $1.5BQ3 2025: $1.6BQ4 2025: $1.7BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.4B
Q4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.5BQ2 2025: $1.5BQ3 2025: $1.6BQ4 2025: $1.7BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.4B
QuarterRevenueYoY
Q3 2026$2.4B+50%
Q2 2026$2B+34%
Q1 2026$1.8B+21%
Q4 2025$1.7B+17%
Q3 2025$1.6B+17%
Q2 2025$1.5B+16%
Q1 2025$1.5B+24%
Q4 2024$1.4B+27%

COHR has the edge over QBTS on sales, with more consistent year-over-year improvement.

QBTS Quarterly Revenue

Q4 2024: $2MQ1 2025: $15MQ2 2025: $3MQ3 2025: $4MQ4 2025: $3MQ1 2026: $3MQ2 2026: $3MQ3 2026: $5M
Q4 2024: $2MQ1 2025: $15MQ2 2025: $3MQ3 2025: $4MQ4 2025: $3MQ1 2026: $3MQ2 2026: $3MQ3 2026: $5M
QuarterRevenueYoY
Q3 2026$4.5M+21%
Q2 2026$3.1M-0.6%
Q1 2026$2.9M-81%
Q4 2025$2.8M+19%

QBTS's revenue is recovering but still below its 2025 peak: $5M last quarter, up 21% from the same quarter a year ago.

COHR Free Cash Flow

Q4 2023: โˆ’$24MQ1 2024: $24MQ2 2024: $62MQ3 2024: $61MQ4 2024: $82MQ1 2025: $51MQ2 2025: โˆ’$1MQ3 2025: โˆ’$58MQ4 2025: โˆ’$96MQ1 2026: โˆ’$383MQ2 2026: โˆ’$486MQ3 2026: โˆ’$868M
Q4 2023: โˆ’$24MQ1 2024: $24MQ2 2024: $62MQ3 2024: $61MQ4 2024: $82MQ1 2025: $51MQ2 2025: โˆ’$1MQ3 2025: โˆ’$58MQ4 2025: โˆ’$96MQ1 2026: โˆ’$383MQ2 2026: โˆ’$486MQ3 2026: โˆ’$868M
QuarterFree cash flowYoY
Q3 2026-$868.2M-$810.2M
Q2 2026-$486.2M-$485.2M
Q1 2026-$383.5M-850%
Q4 2025-$95.7M-217%
Q3 2025-$58M-195%
Q2 2025-$1.1M-102%
Q1 2025$51.1M+111%
Q4 2024$81.7M+$106M

COHR's free cash flow has turned negative after years in the green: โˆ’$1.8B over the past year.

QBTS Free Cash Flow

Q4 2024: $1MQ1 2025: โˆ’$20MQ2 2025: โˆ’$16MQ3 2025: โˆ’$20MQ4 2025: โˆ’$20MQ1 2026: โˆ’$46MQ2 2026: โˆ’$33MQ3 2026: --
Q4 2024: $1MQ1 2025: โˆ’$20MQ2 2025: โˆ’$16MQ3 2025: โˆ’$20MQ4 2025: โˆ’$20MQ1 2026: โˆ’$46MQ2 2026: โˆ’$33MQ3 2026: --
QuarterFree cash flowYoY
Q2 2026-$32.9M-$16.9M
Q1 2026-$46M-$26.3M
Q4 2025-$20M-1977%

QBTS and COHR do not have enough comparable growth data to identify a winner.

COHR Total Shares

Q4 2023: 152MQ1 2024: 152MQ2 2024: 152MQ3 2024: 154MQ4 2024: 160MQ1 2025: 155MQ2 2025: 155MQ3 2025: 191MQ4 2025: 193MQ1 2026: 196MQ2 2026: 195MQ3 2026: 202M
Q4 2023: 152MQ1 2024: 152MQ2 2024: 152MQ3 2024: 154MQ4 2024: 160MQ1 2025: 155MQ2 2025: 155MQ3 2025: 191MQ4 2025: 193MQ1 2026: 196MQ2 2026: 195MQ3 2026: 202M
PeriodChange %Net change
Quarterly+3.4%+6.6M shares
1 year+5.9%+11.3M shares
3 years+34%+51.7M shares
5 years+74%+86.2M shares
Available history+122%+111M shares

COHR has the edge over QBTS on shareholder dilution, with a more favorable share count trend.

QBTS Total Shares

Q1 2025: 286MQ2 2025: 302MQ3 2025: 342MQ4 2025: 321MQ1 2026: 367MQ2 2026: 371M
Q1 2025: 286MQ2 2025: 302MQ3 2025: 342MQ4 2025: 321MQ1 2026: 367MQ2 2026: 371M
PeriodChange %Net change
Quarterly+0.9%+3.4M shares
1 year+23%+68.6M shares

QBTS has 371M diluted shares, up 23% from a year ago.

COHR Net Leverage

Q4 2023: 6.0xQ1 2024: 6.6xQ2 2024: 4.8xQ3 2024: 4.8xQ4 2024: 4.6xQ1 2025: 5.1xQ2 2025: 8.1xQ3 2025: 4.1xQ4 2025: 3.5xQ1 2026: 1.7xQ2 2026: 1.5xQ3 2026: 1.7x
Q4 2023: 6.0xQ1 2024: 6.6xQ2 2024: 4.8xQ3 2024: 4.8xQ4 2024: 4.6xQ1 2025: 5.1xQ2 2025: 8.1xQ3 2025: 4.1xQ4 2025: 3.5xQ1 2026: 1.7xQ2 2026: 1.5xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.5xHealthy
Q1 20261.7xHealthy
Q4 20253.5xElevated
Q3 20254.1xHigh
Q2 20258.1xHigh
Q1 20255.1xHigh
Q4 20244.6xHigh

COHR's net debt is about 1.7 years of its operating earnings (EBITDA), down from 4.1 years a year ago.

QBTS Net Leverage

QBTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

COHR Weekly Momentum

MetricValueStatus
RSI43.6Neutral
Stochastic16.5Oversold

COHR's weekly RSI is 44 (neutral) and its Stochastic is 16 (oversold).

QBTS Weekly Momentum

MetricValueStatus
RSI31.7Neutral
Stochastic10.0Oversold

QBTS's weekly RSI is 32 (neutral) and its Stochastic is 10 (oversold).

COHR PE vs Technology Sector

MetricCOHRSector medianRelative
PE48x28x72% above
PE %583523 pts above

COHR is trading at 48x earnings, a 72% premium to the Technology sector's median of 28x.

QBTS PE vs Technology Sector

QBTS has no meaningful PE right now: it lost money over the past year.

COHR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$252.98.2% below
20 week MA$284.118% below
50 week MA$277.716% below
100 week MA$185.925% above
200 week MA$120.692% above

COHR has the edge over QBTS on trend strength, trading above more of its moving averages.

QBTS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.823% below
20 week MA$16.340% below
50 week MA$19.950% below
100 week MA$17.644% below
200 week MA$9.464% above

QBTS has fallen below most of its moving averages, though it's still 4% above its 200-week average.

COHR Yearly ROI

YearStart priceEnd priceROI
2020$33.5$77.8+132%
2021$77.8$68.0-13%
2022$68.0$33.1-51%
2023$33.1$43.5+32%
2024$43.5$97.0+123%
2025$97.0$191.7+98%
2026 YTD$191.7$232.1+21%

COHR has the edge over QBTS on returns for 2026, with the stronger performance.

QBTS Yearly ROI

YearStart priceEnd priceROI
2020$10.2$10.5+3.4%
2021$10.5$9.79-6.8%
2022$9.79$1.70-83%
2023$1.70$0.88-48%
2024$0.88$9.91+1026%
2025$9.91$25.3+155%
2026 YTD$25.3$9.84-61%

QBTS's yearly returns have swung widely, from +1026% in 2024 to โˆ’83% in 2022. It's down 61% so far in 2026.

Give your agent the market.

Get API key